Kruse leaving Genmab as CFO

Genmab (CSE:GEN) said Bo Kruse will depart as CFO. The antibody company hired David Eatwell to replace him. Previously, Eatwell was CFO of Catalent ( Somerset, N.J.). Genmab, which made the announceme...